Trials Report Galcanezumab Shows Promise At Preventing Migraines

TUESDAY, May 29, 2018 -- Migraine sufferers could soon turn to a number of new medications to avoid their crippling headaches. Earlier this month, the U.S. Food and Drug Administration approved Aimovig (erenumab), the first migraine prevention drug...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news